Guillermo Iborra Lázaro

Mr. Guillermo Iborra Lázaro


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 July 2020 in Biology
Verified
Journal Article
Open access
PDF file
JMJennifer Mayordomo-Cava
Jennifer Mayordomo-Cava
GLGuillermo Iborra Lázaro
Guillermo Iborra Lázaro
SDSouhail Djebari
Souhail Djebari
STSara Temprano-Carazo
Sara Temprano-Carazo
ISIrene Sánchez-Rodríguez
Irene Sánchez-Rodríguez
JNJuan D. Navarro-Lopez
Juan D. Navarro-Lopez
In early Alzheimer disease (AD) models synaptic failures and upstreaming aberrant patterns of network synchronous activity result in hippocampal-dependent memory deficits. In such initial stage, soluble forms of Amyloid-β (Aβ) peptides have been shown to play a causal role. Among different Aβ species, Aβ25–35 has been identified as the biologically active fragment, as induces major neuropathological signs related to early AD stages. Consequently, it has been extensively used to acutely explore the pathophysiological events related with neuronal dysfunction induced by soluble Aβ forms. However, the synaptic mechanisms underlying its toxic effects on hippocampal-dependent memory remain unresolved. Here, in an in vivo model of amyloidosis generated by intracerebroventricular injections of Aβ25–35 we studied the synaptic dysfunction mechanisms underlying hippocampal cognitive deficits. At the synaptic level, long-term potentiation (LTP) of synaptic excitation and inhibition was induced in CA1 region by high frequency simulation (HFS) applied to Schaffer collaterals. Aβ25–35 was found to alter metaplastic mechanisms of plasticity, facilitating long-term depression (LTD) of both types of LTP. In addition, aberrant synchronization of hippocampal network activity was found while at the behavioral level, deficits in hippocampal-dependent habituation and recognition memories emerged. Together, our results provide a substrate for synaptic disruption mechanism underlying hippocampal cognitive deficits present in Aβ25–35 amyloidosis model.

Verified
Journal Article
Open access
PDF file
ILInmaculada Lopez-Font
Inmaculada Lopez-Font
MLMatthew P. Lennol
Matthew P. Lennol
GLGuillermo Iborra Lázaro
Guillermo Iborra Lázaro
HZHenrik Zetterberg
Henrik Zetterberg
KBKaj Blennow
Kaj Blennow
JVJavier Sáez Valero
Javier Sáez Valero
Reelin binds to the apolipoprotein E receptor apoER2 to activate an intracellular signaling cascade. The proteolytic cleavage of reelin follows receptor binding but can also occur independently of its binding to receptors. This study assesses whether reelin proteolytic fragments are differentially affected in the cerebrospinal fluid (CSF) of Alzheimer’s disease (AD) subjects. CSF reelin species were analyzed by Western blotting, employing antibodies against the N- and C-terminal domains. In AD patients, we found a decrease in the 420 kDa full-length reelin compared with controls. In these patients, we also found an increase in the N-terminal 310 kDa fragment resulting from the cleavage at the so-called C-t site, whereas the 180 kDa fragment originated from the N-t site remained unchanged. Regarding the C-terminal proteolytic fragments, the 100 kDa fragment resulting from the cleavage at the C-t site also displayed increased levels, whilst the one resulting from the N-t site, the 250 kDa fragment, decreased. We also detected the presence of an aberrant reelin species with a molecular mass of around 500 kDa present in AD samples (34 of 43 cases), while it was absent in the 14 control cases analyzed. These 500 kDa species were only immunoreactive to N-terminal antibodies. We validated the occurrence of these aberrant reelin species in an Aβ42-treated reelin-overexpressing cell model. When we compared the AD samples from APOE genotype subgroups, we only found minor differences in the levels of reelin fragments associated to the APOE genotype, but interestingly, the levels of fragments of apoER2 were lower in APOE ε4 carriers with regards to APOE ε3/ε3. The altered proportion of reelin/apoER2 fragments and the occurrence of reelin aberrant species suggest a complex regulation of the reelin signaling pathway, which results impaired in AD subjects.

7 December 2020 in Alzheimer's & Dementia
Verified
Journal Article
Closed access
PDF file
GLGuillermo Iborra Lázaro
Guillermo Iborra Lázaro
JMJennifer Mayordomo‐Cava
Jennifer Mayordomo‐Cava
ISIrene Sánchez‐Rodríguez
Irene Sánchez‐Rodríguez
STSara Temprano‐Carazo
Sara Temprano‐Carazo
SDSouhail Djebari
Souhail Djebari
LJLydia Jimenez‐Diaz
Lydia Jimenez‐Diaz